News
-
BioNxt Advances Semaglutide ODF Program into Active Pharmaceutical Development
-
NanoViricides Announces Closing of ~$2 Million Registered Direct Offering
-
Drilling Targets High-Grade Tolmer Silver Extensions
-
Ondas Inc. Stockholders: Vote Now to Ensure Quorum for Annual Meeting
-
Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization
-
H.I.G. Bayside Capital Europe Completes Refinancing of Lifeways Group
-
FAMAR Group announces contract manufacturing agreement with GE HealthCare
-
Original-Research: Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen
-
EQS-Adhoc: Takeda Pharmaceutical Company Limited: Takeda Provides an Update regarding Jury Verdict in AMITIZA® (lubiprostone) Antitrust Litigation in the U.S. and Related Revision to FY2025 Financial Results
-
Wolftank Group expands into fast-growing critical infrastructure and defense markets with U.S. partner High Impact Technology, LLC
-
cegedim.cloud obtient les certifications ISO 14001 et ISO 50001 et renforce sa stratégie de datacenters durables
-
Résultats de l’offre publique de retrait et mise en œuvre du retrait obligatoire à venir sur les titres TERACT
-
Results of the public buy-out offer and implementation of the subsequent squeeze-out of TERACT shares
-
Déclaration des transactions sur actions propres réalisées du 11/05/2026 au 17/05/2026
-
ALPOU - Groupe POULAILLON - Dépôt du projet de note en réponse à l'offre publique d'achat simplifiée